Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Pharmaceutical Science and Technology Meeting of the Faculty of Pharmaceutical Sciences, University of São Paulo. Unidade: FCF
Assunto: LEISHMANIA
ABNT
SOUZA, Aline de e BOU-CHACRA, Nadia Araci. Selection of liquid lipid for development of Nanostructured lipid carrier containing hydroxymethylnitrofurazone (nfoh) for the treatment of leishmania. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 21 out. 2024. , 2017APA
Souza, A. de, & Bou-Chacra, N. A. (2017). Selection of liquid lipid for development of Nanostructured lipid carrier containing hydroxymethylnitrofurazone (nfoh) for the treatment of leishmania. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.NLM
Souza A de, Bou-Chacra NA. Selection of liquid lipid for development of Nanostructured lipid carrier containing hydroxymethylnitrofurazone (nfoh) for the treatment of leishmania. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 28 res. FCF052.[citado 2024 out. 21 ]Vancouver
Souza A de, Bou-Chacra NA. Selection of liquid lipid for development of Nanostructured lipid carrier containing hydroxymethylnitrofurazone (nfoh) for the treatment of leishmania. Brazilian Journal of Pharmaceutical Sciences. 2017 ; 53 28 res. FCF052.[citado 2024 out. 21 ]